Back to Bills
SENATE-BILL 2697119th Congress

SENATE-BILL 2697: S.2697 - National Biotechnology Safety Act

Introduced: September 3, 2025
Status: Referred to Committee
R.for.R

AI-Powered Summary

Generated by AI Analysis

SENATE-BILL 2697 aims to authorize and fund research into biotechnology risk assessment, focusing on the safety of biotechnology products and their potential impacts on health and safety. The major themes addressed include individual rights to health and safety, the right to information, and potential property rights related to biotechnology products. Key provisions include significant funding allocations for research, a comprehensive regulatory process involving multiple federal agencies, and an emphasis on enhancing safety measures for biotechnology products. Implementation requires coordination among federal agencies to ensure effective oversight and timely research outcomes. The potential impacts include improved safety regulations that could benefit individuals, although concerns exist regarding the adequacy of oversight and the risk of regulatory capture, which may undermine individual rights if not properly managed.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill's focus on biotechnology safety has the potential to significantly impact individual rights, particularly concerning health and safety. However, if the regulations resulting from the NSF's research disproportionately affect certain demographic groups, it could lead to violations of equal protection rights.

Key Individual Rights Affected

  • Right to Health and Safety
  • Equal Protection under the Law
  • Right to Information

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • Right to Health and Safety (implied through various amendments)

Potential Constitutional Challenges

  • Disproportionate Impact on Marginalized Groups
  • Lack of Transparency in Regulatory Processes
  • Health Risks from Insufficient Risk Assessment

Summary

The National Biotechnology Safety Act aims to enhance safety and public health through research on biotechnology products. However, it raises constitutional concerns regarding equal protection and the right to health and safety, particularly for vulnerable demographic groups. The potential for unequal impacts necessitates careful implementation to ensure that individual rights are upheld.

Constitutional Analysis

R.for.R

This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 2697 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

September 3, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat